申请人:Warner-Lambert Company
公开号:US05389682A1
公开(公告)日:1995-02-14
The invention concerns a series of novel bis-urea derivatives, nonpeptides, which show good binding affinity for the CCK-B receptor. The compounds, compositions containing them, methods of preparation, and utilities including anxiety, gastric acid secretion inhibition, and psychoses are included.
这项发明涉及一系列新型双脲衍生物,非肽类,它们对CCK-B受体显示出良好的结合亲和力。该化合物、含有它们的组合物、制备方法以及用途包括焦虑、胃酸分泌抑制和精神病等。